Ebola and the Endgame: Whatever the Next Plague, It's Not a Question of If ...
Riley is particularly concerned about Costridium difficile, a gram-positive bacterium associated with intestinal infections that is developing resistance to a wide spectrum of antibiotics. “It was once pretty much confined to hospitals, but it's now ...
CALIFORNIA - Wed, 01 Oct 2014 17:31

Once-Weekly Antibiotic Might Be Effective for Treatment of Acute Bacterial ...
Background: Acute bacterial skin infections are common and often require hospitalization for intravenous antibiotic administration. Treatment covering gram-positive bacteria usually is indicated. Dalbavancin is effective against gram-positives ...
The Hospitalist Online - Wed, 01 Oct 2014 11:45

Durata Therapeutics to Present Five Posters at IDWeek 2014
CHICAGO, Oct. 2, 2014 (GLOBE NEWSWIRE) -- Durata Therapeutics (Nasdaq:DRTX) today announced that it will present five posters highlighting data from its recently launched product, DALVANCE™ (dalbavancin) for injection, at IDWeek 2014, which takes ...
CNNMoney - Thu, 02 Oct 2014 05:56

Cubist to Present New Data on Antibiotics Portfolio at IDWeek 2014
“Cubist is committed to developing antibiotics to address serious infections, including those caused by Gram-positive and Gram-negative bacteria,” said Steven Gilman, Ph.D., Executive Vice President of Research and Development and Chief Scientific ...
Business Wire (press release) - Tue, 30 Sep 2014 05:22

Have our bodies held the key to new antibiotics all along?
As the threat of antibiotic resistance grows, scientists are turning to the human body and the trillion or so bacteria that have colonized us — collectively called our microbiota — for new clues to fighting microbial infections. They've logged an ...
Science Codex - Wed, 01 Oct 2014 07:03



Bacteria Causing Eye Infections Increasingly Resistant To Common Antibiotics
The most common cause of endophthalmitis in the study was bacteria, 95%, with most, 85%, being Gram-positive bacteria. The most prevalent organisms isolated were coagulase-negative staphylococcus, making up about 40% of the cases. This was ...
Medical Research News and Interviews_ MedicalResearch.com - Tue, 26 Aug 2014 08:33



Mining The Microbiome For Therapeutics
The semisynthetic molecule, LFF571, is now being evaluated in Phase II clinical trials as a treatment for gastrointestinal infections caused by the bacterium Clostridium difficile. Despite coming from two completely different types of bacteria, the ...
The Biological SCENE - Sun, 28 Sep 2014 22:51

Dr. Marla: Examining the link between antibiotics and childhood obesity
Broad-spectrum antibiotics are active against a wider number of bacterial types and, thus, may be used to treat a variety of infectious diseases and is effective against a wide range of infectious microorganisms which includes both gram positive and ...
CTV News - Tue, 30 Sep 2014 00:18


1  2  3  4  5  6  7  8    ->


We do not evaluate or guarantee the accuracy of any content in this site. Click here for the full disclaimer.

Last update: September 2014